Alto Neuroscience (ANRO)
30.92
+0.67 (2.21%)
Upcoming Events
Latest Headlines
Alto Neuroscience Announces Participation in Upcoming Investor Conferences
September 9, 2026 8:03 AM - BizWire
Form 8-K Alto Neuroscience, Inc. For: Aug 26
August 27, 2026 5:19 PM - SEC Filing
Alto Neuroscience promotes Nick Smith to president and CFO
August 27, 2026 4:05 PM - StreetInsider
Alto Neuroscience Promotes Nick Smith to President and Chief Financial Officer
August 27, 2026 4:05 PM - BizWire
Alto Neuroscience (ANRO) PT Raised to $55 at H.C. Wainwright
August 18, 2026 6:39 AM - StreetInsider
Form SCHEDULE 13G/A Alto Neuroscience, Inc. Filed by: PERCEPTIVE ADVISORS LLC
August 14, 2026 5:19 PM - SEC Filing
Form SCHEDULE 13G/A Alto Neuroscience, Inc. Filed by: Vestal Point Capital, LP
August 14, 2026 4:12 PM - SEC Filing
Form SCHEDULE 13G/A Alto Neuroscience, Inc. Filed by: Sirenia Capital Management LP
August 14, 2026 8:30 AM - SEC Filing
Alto Neuroscience, Inc. (ANRO) Tops Q2 EPS by 10c
August 12, 2026 5:16 PM - StreetInsider
Form 10-Q Alto Neuroscience, Inc. For: Jun 30
August 12, 2026 4:28 PM - SEC Filing
Form 8-K Alto Neuroscience, Inc. For: Aug 12
August 12, 2026 4:15 PM - SEC Filing
Alto Neuroscience Reports Second Quarter 2026 Financial Results and Recent Business Highlights
August 12, 2026 4:03 PM - BizWire
Form SCHEDULE 13G Alto Neuroscience, Inc. Filed by: BlackRock, Inc.
July 27, 2026 4:27 PM - SEC Filing
Form SCHEDULE 13G Alto Neuroscience, Inc. Filed by: EcoR1 Capital, LLC
July 20, 2026 5:11 PM - SEC Filing
Form 8-K Alto Neuroscience, Inc. For: Jul 13
July 14, 2026 6:05 AM - SEC Filing
Form 424B5 Alto Neuroscience, Inc.
July 14, 2026 6:04 AM - SEC Filing
Alto Neuroscience prices $100M stock offering to fund depression trial
July 13, 2026 7:47 AM - StreetInsider
Alto Neuroscience Announces Pricing of $100.0 Million Underwritten Registered Direct Offering of Common Stock
July 13, 2026 7:47 AM - BizWire
Form 8-K Alto Neuroscience, Inc. For: Jul 13
July 13, 2026 7:39 AM - SEC Filing
Full Article List
